Celcuity News

Celcuity(CELC.US) Director Sells US$5,971 in Common Stock

$Celcuity(CELC.US)$ Director Buller Richard E sold 350 shares of common stock on Apr 24, 2024 at an average price of $17.06 for a total value of $5,971.Source: Announcement What is statement of change

moomoo News17:39 ET

Institutional Investors May Overlook Celcuity Inc.'s (NASDAQ:CELC) Recent US$51m Market Cap Drop as Long-term Gains Remain Positive

Key Insights Given the large stake in the stock by institutions, Celcuity's stock price might be vulnerable to their trading decisions 51% of the business is held by the top 6 shareholders 14% of

Simply Wall StApr 13 09:14 ET

Needham Reiterates Buy on Celcuity, Maintains $24 Price Target

Needham analyst Gil Blum reiterates Celcuity (NASDAQ:CELC) with a Buy and maintains $24 price target.

BenzingaApr 12 06:13 ET

Celcuity: A Promising Buy in Healthcare Innovation and Personalized Oncology Solutions

TipRanksApr 12 06:07 ET

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

MINNEAPOLIS, April 04, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief

GlobeNewswireApr 4 07:05 ET

Celcuity (NASDAQ:CELC): A Biotech With Game-Changing Blockbuster Potential

TipRanksApr 3 00:06 ET

Celcuity Inc. (NASDAQ:CELC) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 1 13:38 ET

Celcuity Inc.'s Balancing Act: Navigating Financial Risks in Capital Raising Endeavors

TipRanksMar 29 02:01 ET

Celcuity Is Maintained at Buy by Craig-Hallum

Celcuity Is Maintained at Buy by Craig-Hallum

Dow JonesMar 28 14:29 ET

Celcuity Up Over 20%, on Track for Highest Close Since September 2021 -- Data Talk

Celcuity Inc. (CELC) is currently at $21.88, up $3.72 or 20.48% --Would be highest close since Sept. 8, 2021, when it closed at $21.91 --On pace for largest percent increase since Dec. 19, 2022, whe

Dow JonesMar 28 14:26 ET

Express News | Celcuity Shares Are Trading Higher After the Company Reported Better-than-expected Q4 EPS Results. Also, Needham Maintained a Buy Rating on the Stock and Raised Its Price Target From $23 to $24

Moomoo 24/7Mar 28 12:33 ET

Craig Hallum Adjusts Celcuity Price Target to $25 From $20, Maintains Buy Rating

Celcuity (CELC) has an average rating of Buy and price targets ranging from $24 to $40, according to analysts polled by Capital IQ. Price: 20.83, Change: +2.67, Percent Change: +14.61

MT NewswiresMar 28 12:11 ET

Stifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC)

TipRanksMar 28 06:55 ET

Q4 2023 Celcuity Inc Earnings Call

Yahoo FinanceMar 28 06:51 ET

Express News | HC Wainwright & Co. Reiterates Buy on Celcuity, Maintains $27 Price Target

Moomoo 24/7Mar 28 06:08 ET

Celcuity Is Maintained at Buy by Needham

Celcuity Is Maintained at Buy by Needham

Dow JonesMar 28 06:08 ET

Analysts Are Bullish on These Healthcare Stocks: Celcuity (CELC), Cara Therapeutics (CARA)

TipRanksMar 28 06:00 ET

Express News | Needham Maintains Buy on Celcuity, Raises Price Target to $24

Moomoo 24/7Mar 28 05:59 ET

Celcuity Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 36.36% Needham $23 → $24 Maintains Buy 02/22/2024 127.27% Stifel → $40 Initiates Coverage On →

BenzingaMar 28 05:57 ET

Earnings Call Summary | Celcuity(CELC.US) Q4 2023 Earnings Conference

The following is a summary of the Celcuity Inc. (CELC) Q4 2023 Earnings Call Transcript:Financial Performance:Celcuity's Q4 net loss was $18.8 million, an increase from its loss of $11.6 million in Q4

moomoo AIMar 27 19:34 ET · Conference Call